Kazia Therapeutics (KZIA) Minority Interest (2009 - 2015)
Kazia Therapeutics' (KZIA) quarterly Minority Interest came in at -$218066.1 in Q4 2015, down 160.13% YoY from $362668.3 in Q4 2014, and up 7.43% on a QoQ basis from -$235559.1 in Q2 2015.
Kazia Therapeutics (KZIA) Minority Interest (2009 - 2015) Analysis & Trends
Kazia Therapeutics (KZIA) has 7 years of Minority Interest data on file, last reported at -$218066.1 in Q4 2015.
- Quarterly Minority Interest fell 160.13% year-over-year to -$218066.1 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was -$218066.1 (down 160.13% YoY) and the FY2015 annual result came in at -$228066.6, down 157.91% from the prior year.
- Minority Interest advanced to -$218066.1 in Q4 2015, from -$235559.1 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $1.7 million in Q4 2012 to a low of -$235559.1 in Q2 2015.
- A 5-year average of $435534.0 and a median of -$15093.0 in 2013 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2012 — Minority Interest surged 716.27% — and 2014, when it slumped 455.42%.
- Tracing KZIA's Minority Interest over 5 years: stood at $1.0 million in 2011, then jumped by 68.96% to $1.7 million in 2012, then slumped by 100.89% to -$15093.0 in 2013, then tumbled by 455.42% to -$83830.2 in 2014, then slumped by 160.13% to -$218066.1 in 2015.
- The last three Minority Interest figures came in at -$218066.1 (Q4 2015), -$235559.1 (Q2 2015), and -$83830.2 (Q4 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -218,066.11 |
| Jun 30, 2015 | -235,559.10 |
| Dec 31, 2014 | -83,830.23 |
| Jun 30, 2014 | -91,384.76 |
| Dec 31, 2013 | -15,093.00 |
| Dec 31, 2012 | 1.70 Mn |
| Jun 30, 2012 | 1.66 Mn |
| Dec 31, 2011 | 1.01 Mn |
| Jun 30, 2011 | 202,781.60 |
| Dec 31, 2010 | 590,000.00 |
| Jun 30, 2010 | 1.76 Mn |
| Dec 31, 2009 | 3.25 Mn |
| Jun 30, 2009 | 3.87 Mn |